Clinical Trials Directory

Trials / Completed

CompletedNCT04704128

Identification of Pathophysiological Pathways and Therapeutic Targets in Primary Stomatodynia by Salivary Metabolomics

Identification de Voies Physiopathologiques et Cibles thérapeutiques Dans la Stomatodynie Primaire (" Burning Mouth Syndrome ") Par la métabolomique Salivaire : étude Cas/témoins

Status
Completed
Phase
Study type
Observational
Enrollment
53 (actual)
Sponsor
University Hospital, Tours · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Accepted

Summary

Burning mouth syndrome (BMS) is defined by a chronic oral pain affecting especially postmenopausal women. Its physiopathology is still unknown and several hypotheses have been put forward to explain this syndrome, such as neurological, hormonal or inflammatory process. The recent development of salivary metabolomic profiling in oral diseases has led to the identification of potential pathways in such disorders. The aim of this study is to analyze the salivary metabolomic in BMS patients compared to healthy controls.

Detailed description

Burning mouth syndrome (BMS) is defined by a chronic oral pain affecting especially postmenopausal women. Its physiopathology is still unknown and several hypotheses have been put forward to explain this syndrome, such as neurological, hormonal or inflammatory process. The recent development of salivary metabolomic profiling in oral diseases has led to the identification of potential pathways in such disorders. The aim of this study is to analyze the salivary metabolomic in BMS patients compared to healthy controls.

Conditions

Interventions

TypeNameDescription
OTHERSalivic sampleCollection of total saliva not stimulated

Timeline

Start date
2021-03-10
Primary completion
2021-05-12
Completion
2021-05-12
First posted
2021-01-11
Last updated
2021-07-07

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04704128. Inclusion in this directory is not an endorsement.